StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.87+0.26 (+5.64%)

Close on Nov 18, 2026Market cap $61.16MP/E –Yield –

Earnings

Neuraxis's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q4 FY2024
$800.00K
+50.5% on a year earlier
EPS, Q4 FY2024
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Neuraxis's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2026ended Mar 31, 2026Apr 21, 2026after the close–––Filing
Q3 FY2025ended Sep 30, 2025Oct 23, 2025after the close–––Filing
Q4 FY2024ended Dec 31, 2024Jan 8, 2025before the open$800.00K+50.5%–Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$667.00K––Release
Q2 FY2024ended Jun 30, 2024Aug 9, 2024before the open$611.50K-5.3%–Release
Q1 FY2024ended Mar 31, 2024Apr 9, 2024after the close$531.50K––Release
Q4 FY2023ended Dec 31, 2023Apr 9, 2024after the close$531.50K––Release
Q2 FY2023ended Jun 30, 2023Sep 21, 2023before the open$646.00K–-$1.21Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Neuraxis has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Neuraxis puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Neuraxis filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?